Combination of bevacizumab (B) plus immunotherapy, with interleukin-2 (IL-2) and interferon-α (IFN-α) plus chemotherapy (BIC) in patients with metastatic renal cell cancer (mRCC): Dose-finding phase ...

The finding in patients who had experienced a first episode of deep-venous thrombosis or pulmonary embolism suggests that the d-dimer test "may be useful in guiding the duration of anticoagulation by ...

Venous thromboembolism (VTE), which most especially includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major cause of morbidity and mortality worldwide and represents a ...

A 68-year-old African American woman with a medical history of diabetes, hypertension, gout, and obesity presented with 2 days of shortness of breath and cough. Vital signs were temperature 37.1 °C, ...

Bologna 8 April 2022 - Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than one-quarter of patients with COVID-19 had ...

Anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer: A meta-analysis. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

D-dimer can be a useful tool in the management of patients with suspected or established venous thromboembolism (VTE). One use is in the assessment of a patient who presents with symptoms of VTE.

HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments. The new Yumizen GDDi 2 (D-Dimer) reagent kit is now available for HORIBA Medical’s ...